Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacy.

van den Blink B, Dillingh MR, Ginns LC, Morrison LD, Moerland M, Wijsenbeek M, Trehu EG, Bartholmai BJ, Burggraaf J.

Eur Respir J. 2016 Mar;47(3):889-97. doi: 10.1183/13993003.00850-2015. Epub 2016 Feb 11.

PMID:
26869678
2.

Quantitative proteomics of bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis.

Foster MW, Morrison LD, Todd JL, Snyder LD, Thompson JW, Soderblom EJ, Plonk K, Weinhold KJ, Townsend R, Minnich A, Moseley MA.

J Proteome Res. 2015 Feb 6;14(2):1238-49. doi: 10.1021/pr501149m. Epub 2015 Jan 14.

PMID:
25541672
3.

Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial.

Raghu G, Behr J, Brown KK, Egan JJ, Kawut SM, Flaherty KR, Martinez FJ, Nathan SD, Wells AU, Collard HR, Costabel U, Richeldi L, de Andrade J, Khalil N, Morrison LD, Lederer DJ, Shao L, Li X, Pedersen PS, Montgomery AB, Chien JW, O'Riordan TG; ARTEMIS-IPF Investigators*.

Ann Intern Med. 2013 May 7;158(9):641-9. doi: 10.7326/0003-4819-158-9-201305070-00003. Erratum in: Ann Intern Med. 2014 May 6;160(9):658.

PMID:
23648946
4.

Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle.

Meltzer EB, Barry WT, D'Amico TA, Davis RD, Lin SS, Onaitis MW, Morrison LD, Sporn TA, Steele MP, Noble PW.

BMC Med Genomics. 2011 Oct 5;4:70. doi: 10.1186/1755-8794-4-70.

5.

Death by quinine.

Morrison LD, Velez LI, Shepherd G, Bey T, Benitez FL.

Vet Hum Toxicol. 2003 Dec;45(6):303-6.

PMID:
14640479
6.

Polyamines in a genetic animal model of paroxysmal dyskinesia.

Richter A, Morrison LD.

Brain Res. 2003 Aug 15;981(1-2):168-73.

PMID:
12885438
8.

CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo.

Agadjanyan MG, Kim JJ, Trivedi N, Wilson DM, Monzavi-Karbassi B, Morrison LD, Nottingham LK, Dentchev T, Tsai A, Dang K, Chalian AA, Maldonado MA, Williams WV, Weiner DB.

J Immunol. 1999 Mar 15;162(6):3417-27.

9.

Engineering DNA vaccines via co-delivery of co-stimulatory molecule genes.

Kim JJ, Nottingham LK, Wilson DM, Bagarazzi ML, Tsai A, Morrison LD, Javadian A, Chalian AA, Agadjanyan MG, Weiner DB.

Vaccine. 1998 Nov;16(19):1828-35.

PMID:
9795388
10.

Coadministration of IL-12 or IL-10 expression cassettes drives immune responses toward a Th1 phenotype.

Kim JJ, Maguire HC Jr, Nottingham LK, Morrison LD, Tsai A, Sin JI, Chalian AA, Weiner DB.

J Interferon Cytokine Res. 1998 Jul;18(7):537-47.

PMID:
9712370
11.
12.

Brain S-adenosylmethionine levels are severely decreased in Alzheimer's disease.

Morrison LD, Smith DD, Kish SJ.

J Neurochem. 1996 Sep;67(3):1328-31.

PMID:
8752143
13.

Brain polyamine levels are altered in Alzheimer's disease.

Morrison LD, Kish SJ.

Neurosci Lett. 1995 Sep 1;197(1):5-8.

PMID:
8545054
14.

Polyamines in human brain: regional distribution and influence of aging.

Morrison LD, Becker L, Ang LC, Kish SJ.

J Neurochem. 1995 Aug;65(2):636-42.

PMID:
7616219
15.

The posterior cruciate ligament in total knee surgery. Save, sacrifice, or substitute?

Hirsch HS, Lotke PA, Morrison LD.

Clin Orthop Relat Res. 1994 Dec;(309):64-8.

PMID:
7994978
16.
17.

S-adenosylmethionine decarboxylase in human brain. Regional distribution and influence of aging.

Morrison LD, Becker L, Kish SJ.

Brain Res Dev Brain Res. 1993 Jun 8;73(2):237-41.

PMID:
8353934
18.

Brain S-adenosylmethionine decarboxylase activity is increased in Alzheimer's disease.

Morrison LD, Bergeron C, Kish SJ.

Neurosci Lett. 1993 May 14;154(1-2):141-4.

PMID:
8361629
19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk